139 related articles for article (PubMed ID: 16368533)
1. Posttranslational modifications of Bcl2 family members--a potential therapeutic target for human malignancy.
Basu A; DuBois G; Haldar S
Front Biosci; 2006 May; 11():1508-21. PubMed ID: 16368533
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of Bcl2 and regulation of apoptosis.
Ruvolo PP; Deng X; May WS
Leukemia; 2001 Apr; 15(4):515-22. PubMed ID: 11368354
[TBL] [Abstract][Full Text] [Related]
3. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance.
Deng X; Kornblau SM; Ruvolo PP; May WS
J Natl Cancer Inst Monogr; 2001; (28):30-7. PubMed ID: 11158204
[TBL] [Abstract][Full Text] [Related]
5. Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells.
Haldar S; Basu A; Croce CM
Cancer Res; 1998 Apr; 58(8):1609-15. PubMed ID: 9563469
[TBL] [Abstract][Full Text] [Related]
6. Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma.
Yang MC; Loh JK; Li YY; Huang WS; Chou CH; Cheng JT; Wang YT; Lieu AS; Howng SL; Hong YR; Chou AK
Int J Oncol; 2015 Mar; 46(3):1304-16. PubMed ID: 25586056
[TBL] [Abstract][Full Text] [Related]
7. Signal-induced site specific phosphorylation targets Bcl2 to the proteasome pathway.
Basu A; Haldar S
Int J Oncol; 2002 Sep; 21(3):597-601. PubMed ID: 12168105
[TBL] [Abstract][Full Text] [Related]
8. AMBRA1, a Novel BH3-Like Protein: New Insights Into the AMBRA1-BCL2-Family Proteins Relationship.
Di Rita A; Strappazzon F
Int Rev Cell Mol Biol; 2017; 330():85-113. PubMed ID: 28215535
[TBL] [Abstract][Full Text] [Related]
9. Bcl2 family proteins in carcinogenesis and the treatment of cancer.
Frenzel A; Grespi F; Chmelewskij W; Villunger A
Apoptosis; 2009 Apr; 14(4):584-96. PubMed ID: 19156528
[TBL] [Abstract][Full Text] [Related]
10. Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions.
Deng X; Gao F; Flagg T; May WS
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):153-8. PubMed ID: 14660795
[TBL] [Abstract][Full Text] [Related]
11. Bcl2 is the guardian of microtubule integrity.
Haldar S; Basu A; Croce CM
Cancer Res; 1997 Jan; 57(2):229-33. PubMed ID: 9000560
[TBL] [Abstract][Full Text] [Related]
12. IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin.
Hilmi C; Larribere L; Giuliano S; Bille K; Ortonne JP; Ballotti R; Bertolotto C
J Invest Dermatol; 2008 Jun; 128(6):1499-505. PubMed ID: 18079751
[TBL] [Abstract][Full Text] [Related]
13. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1.
Gojo I; Zhang B; Fenton RG
Clin Cancer Res; 2002 Nov; 8(11):3527-38. PubMed ID: 12429644
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the antiapoptotic Bcl-2 family member myeloid cell leukemia-1 (Mcl-1) and the stimulation of its message by gonadotropins in the rat ovary.
Leo CP; Hsu SY; Chun SY; Bae HW; Hsueh AJ
Endocrinology; 1999 Dec; 140(12):5469-77. PubMed ID: 10579309
[TBL] [Abstract][Full Text] [Related]
15. Mcl-1 targeting could be an intriguing perspective to cure cancer.
De Blasio A; Vento R; Di Fiore R
J Cell Physiol; 2018 Nov; 233(11):8482-8498. PubMed ID: 29797573
[TBL] [Abstract][Full Text] [Related]
16. Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1.
Pathan N; Aime-Sempe C; Kitada S; Basu A; Haldar S; Reed JC
Neoplasia; 2001; 3(6):550-9. PubMed ID: 11774038
[TBL] [Abstract][Full Text] [Related]
17. Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
Poruchynsky MS; Wang EE; Rudin CM; Blagosklonny MV; Fojo T
Cancer Res; 1998 Aug; 58(15):3331-8. PubMed ID: 9699663
[TBL] [Abstract][Full Text] [Related]
18. p53 mediates bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway.
Thomas A; Giesler T; White E
Oncogene; 2000 Nov; 19(46):5259-69. PubMed ID: 11077443
[TBL] [Abstract][Full Text] [Related]
19. The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.
Hata AN; Engelman JA; Faber AC
Cancer Discov; 2015 May; 5(5):475-87. PubMed ID: 25895919
[TBL] [Abstract][Full Text] [Related]
20. MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol.
Domina AM; Vrana JA; Gregory MA; Hann SR; Craig RW
Oncogene; 2004 Jul; 23(31):5301-15. PubMed ID: 15241487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
